Ryvu Therapeutics S.A.
RVU.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | PLN 160,073 | PLN 57,939 | PLN 101,917 | PLN 83,236 |
| Short-Term Investments | PLN 65,857 | PLN 175,733 | PLN 528 | PLN 4,994 |
| Receivables | PLN 20,916 | PLN 9,187 | PLN 5,051 | PLN 11,741 |
| Inventory | PLN 1,210 | PLN 2,118 | PLN 1,759 | PLN 1,957 |
| Other Curr. Assets | PLN 24,911 | PLN 33,416 | PLN 258,675 | PLN 2,321 |
| Total Curr. Assets | PLN 272,436 | PLN 278,393 | PLN 367,930 | PLN 104,248 |
| Property Plant & Equip (Net) | PLN 72,734 | PLN 77,554 | PLN 82,219 | PLN 91,182 |
| Goodwill | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Intangibles | PLN 8,116 | PLN 6,337 | PLN 4,276 | PLN 3,044 |
| Long-Term Investments | PLN 16,774 | PLN 16,904 | PLN 20,475 | PLN 24,410 |
| Tax Assets | PLN 65,328 | PLN 0 | -PLN 20,475 | PLN 331 |
| Other NC Assets | -PLN 56,611 | PLN 24,014 | PLN 20,552 | PLN 5,597 |
| Total NC Assets | PLN 106,341 | PLN 124,809 | PLN 107,047 | PLN 124,565 |
| Other Assets | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Total Assets | PLN 378,777 | PLN 403,202 | PLN 474,977 | PLN 228,813 |
| Liabilities | – | – | – | – |
| Payables | PLN 31,150 | PLN 23,142 | PLN 12,579 | PLN 11,689 |
| Short-Term Debt | PLN 791 | PLN 541 | PLN 1,903 | PLN 2,751 |
| Tax Payable | PLN 2,226 | PLN 1,962 | PLN 992 | PLN 6,676 |
| Deferred Revenue | PLN 0 | PLN 25,305 | PLN 13,624 | PLN 19,261 |
| Other Curr. Liab. | PLN 73,761 | PLN 18,753 | PLN 15,716 | -PLN 4,178 |
| Total Curr. Liab. | PLN 107,928 | PLN 69,703 | PLN 44,814 | PLN 36,200 |
| LT Debt | PLN 74,723 | PLN 365 | PLN 865 | PLN 2,318 |
| Deferred Rev, NC | PLN 42,738 | PLN 64,256 | PLN 75,803 | PLN 20,257 |
| Deferred Tax Liab, NC | PLN 0 | PLN 0 | PLN 0 | PLN 438 |
| Other NC Liab. | PLN 9,504 | PLN 9,286 | PLN 10,105 | PLN 8,298 |
| Total NC Liab. | PLN 126,965 | PLN 73,907 | PLN 86,771 | PLN 31,311 |
| Other Liabilities | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Cap. Leases | PLN 1,889 | PLN 779 | PLN 1,894 | PLN 3,494 |
| Total Liabilities | PLN 234,893 | PLN 143,610 | PLN 131,585 | PLN 59,392 |
| Equity | – | – | – | – |
| Pref Stock | PLN 0 | PLN 0 | PLN 35,117 | PLN 300,987 |
| Common Stock | PLN 9,248 | PLN 9,248 | PLN 7,342 | PLN 7,342 |
| Retained Earnings | -PLN 111,444 | -PLN 10 | PLN 92,103 | PLN 175,884 |
| AOCI | -PLN 273,668 | -PLN 269,394 | -PLN 35,117 | -PLN 300,987 |
| Other Equity | PLN 519,748 | PLN 519,748 | PLN 243,945 | -PLN 21,924 |
| Total Equity | PLN 143,884 | PLN 259,592 | PLN 343,392 | PLN 161,302 |
| Supplemental Information | – | – | – | – |
| Minority Interest | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Total Liab. & Tot. Equity | PLN 378,777 | PLN 403,202 | PLN 474,977 | PLN 228,813 |
| Net Debt | -PLN 84,559 | -PLN 57,033 | -PLN 99,149 | -PLN 78,167 |